Search alternatives:
marked decrease » marked increase (Expand Search)
large decrease » large increases (Expand Search), large degree (Expand Search)
do mean » log mean (Expand Search), day mean (Expand Search)
marked decrease » marked increase (Expand Search)
large decrease » large increases (Expand Search), large degree (Expand Search)
do mean » log mean (Expand Search), day mean (Expand Search)
-
1
Data Sheet 1_Emotional prompting amplifies disinformation generation in AI large language models.docx
Published 2025“…Introduction<p>The emergence of artificial intelligence (AI) large language models (LLMs), which can produce text that closely resembles human-written content, presents both opportunities and risks. …”
-
2
-
3
-
4
Marginal means – Pooled across scenarios.
Published 2025“…A randomized conjoint experiment and a follow-up choice experiment revealed that support for the EIAs decreased sharply as their accuracy gap grew, although impact parity was prioritized more when ETAs produced large outcome discrepancies. …”
-
5
-
6
-
7
-
8
A novel RNN architecture to improve the precision of ship trajectory predictions
Published 2025“…To solve these challenges, Recurrent Neural Network (RNN) models have been applied to STP to allow scalability for large data sets and to capture larger regions or anomalous vessels behavior. …”
-
9
-
10
-
11
-
12
-
13
-
14
DoLP characterization of clustering results.
Published 2024“…Error bars represent the bootstrapped mean DoLP and its 95% CI for each cluster. Found clusters are ranked by decreasing mean DoLP (x-axis). …”
-
15
ECoG timescales decrease during spatial attention.
Published 2025“…Bottom: timescales significantly decrease during covert attention relative to the attend-out condition (two locations: <i>p</i> = 0.0244; four locations: <i>p</i> < 0.0001; mean ± SEM; whiskers indicate maximum and minimum; dots correspond to individual electrodes). …”
-
16
-
17
Overview of the six original ACTIV-3/TICO trials.
Published 2025“…</p><p>Conclusions</p><p>In patients hospitalized with COVID-19, treatment with nMAbs did not decrease long-term anti-nucleocapsid response compared to placebo, suggesting neutralizing therapies do not suppress the endogenous humoral immune response in this population.…”
-
18
-
19
-
20